» Authors » Edwin Tan

Edwin Tan

Explore the profile of Edwin Tan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 60
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Masnoon N, George C, Lo S, Tan E, Bordia A, Hilmer S
Expert Rev Clin Pharmacol . 2023 Dec; 17(1):33-56. PMID: 38145414
Introduction: This is a systematic review of prescribing, clinical, patient-reported, and health utilization outcomes of goal-directed medication reviews in older adults. Methods: A systematic review was conducted using MEDLINE, EMBASE,...
2.
Aasted M, Groen A, Keane J, Dabelsteen S, Tan E, Schnabel J, et al.
Mol Cancer Ther . 2023 Jul; 22(10):1204-1214. PMID: 37451822
The lack of antibodies with sufficient cancer selectivity is currently limiting the treatment of solid tumors by immunotherapies. Most current immunotherapeutic targets are tumor-associated antigens that are also found in...
3.
Reeve E, Chenoweth L, Sawan M, Nguyen T, Kalisch Ellett L, Gilmartin-Thomas J, et al.
J Alzheimers Dis . 2022 Dec; 91(3):933-960. PMID: 36530085
Background: Historically, research questions have been posed by the pharmaceutical industry or researchers, with little involvement of consumers and healthcare professionals. Objective: To determine what questions about medicine use are...
4.
Chan A, Smith S, Tan E, Kuruvath S
Am J Trop Med Hyg . 2022 Jan; 106(3):861-866. PMID: 35026730
Acanthamoeba brain abscess is very rare and most often fatal. There remains no standardized regimen for its management. We report a case in northern Australia of an immunosuppressed 57-year-old man...
5.
Romer T, Koed Moller Aasted M, Dabelsteen S, Groen A, Schnabel J, Tan E, et al.
Br J Cancer . 2021 Sep; 125(9):1239-1250. PMID: 34526666
Background: Novel immunotherapies targeting cancer-associated truncated O-glycans Tn (GalNAcα-Ser/Thr) and STn (Neu5Acα2-6GalNacα-Ser/Thr) are promising strategies for cancer treatment. However, no comprehensive, antibody-based mapping of truncated O-glycans in tumours exist to...
6.
Schafer C, Ju Y, Tak Y, Vazquez C, Han S, Tan E, et al.
Heliyon . 2020 Feb; 6(1):e03263. PMID: 32021935
Purpose: Over 90% of all cancer related deaths are due to metastasis. However, current diagnostic tools can't reliably discriminate between invasive and localized cancers. Patients And Methods: In this proof-of-concept...
7.
Ozkan Kucuk N, Sanal E, Tan E, Mitchison T, Ozlu N
J Proteome Res . 2018 Apr; 17(5):1784-1793. PMID: 29651847
Quantitative profiling of cell surface proteins is critically important for the understanding of cell-cell communication, signaling, tissue development, and homeostasis. Traditional proteomics methods are challenging for cell surface proteins due...
8.
Gaerty K, Thomas J, Petersen S, Tan E, Kumar S, Gardener G, et al.
Pediatr Dev Pathol . 2015 Sep; 19(2):154-8. PMID: 26367770
An unusual anatomic configuration of segmental tracheal agenesis/atresia with esophageal duplication on autopsy in a fetus that demised in utero at 29 weeks is reported. The mother was scanned initially...
9.
Tan E, Lie D, Wong M
Orthopedics . 2014 Oct; 37(9):e822-7. PMID: 25350626
Proximal humerus fractures are commonly encountered in elderly patients. Surgical treatment demonstrates high complication rates, including varus construct collapse and screw cutout. In this study, the authors evaluate the clinical...
10.
Tan E, Stewart K, Elliott R, George J
BMC Health Serv Res . 2012 Aug; 12:246. PMID: 22876813
Background: Medication-related problems are a serious concern in Australian primary care. Pharmacist interventions have been shown to be effective in identifying and resolving these problems. Collaborative general practitioner-pharmacist services currently...